Peptide PET scan could light up hidden cancer targets
NCT ID NCT07319130
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new PET/CT imaging method that uses a radioactive peptide to find a protein called Nectin-4 on solid tumors. Researchers will scan 10 people with cancers like breast or bladder cancer that have high Nectin-4 levels. The goal is to see if this scan can show where the protein is in the body, which could help doctors plan better treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 68Ga-labeled Nectin-4 bicyclic peptide
- What this could lead to
- If successful, this could provide a non-invasive way to see Nectin-4 levels in tumors, helping doctors choose better treatments and monitor disease.
- What could go wrong
- This is a very early, small study with only 10 participants, so results may not apply widely. The imaging method may not be accurate enough or could have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS WITH HIGH EXPRESSION OF NECTIN4 are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215000, China